Summary
Updated Aug 30, 2026
Manuel Md Litchman is President, CEO and Interim CFO, Director of MUSTANG BIO, INC. (MBIO). 1 SEC Form 4 filing on record, dated 27 April 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Manuel Md Litchman has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Manuel Md Litchman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Peter A. Thompson - $55.67M of SION open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M of SION open-market activity in the last 12 months
- Mark A. Goldsmith - $54.82M of RVMD open-market activity in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $54.63M of WVE open-market activity in the last 12 months
- Neil Kumar - $53.07M of BBIO open-market activity in the last 12 months
- Randal J. Kirk - $52.87M of PGEN open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Manuel Md Litchman?
Manuel Md Litchman is a corporate insider, tracked as President, CEO and Interim CFO, Director of MUSTANG BIO, INC. (MBIO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Manuel Md Litchman last file a Form 4?
The only primary Form 4 on record is dated 27 April 2026.
Where can I see all of Manuel Md Litchman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Manuel Md Litchman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
